Mobile

An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of oseltamivir (Tamiflu) in the treatment of infants 0 to <12 months of age with laboratory confirmed influenza infect...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-014365-12

An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of oseltamivir (Tamiflu) in the treatment of infants 0 to <12 months of age with laboratory confirmed influenza infection

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to define the pharmacokinetics of oseltamivir and oseltamivir carboxylate in children with confirmed influenza up to one year of age.

Critère d'inclusion

  • Treatment of influenza

Liens